These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1910321)

  • 1. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic detection of anti-erythrocyte alloimmunization during pregnancy. Experience at the Lyon Regional Blood Transfusion Center].
    Moncharmont P; Juron-Dupraz F; Vignal M; Rigal D
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):321-4. PubMed ID: 2500475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 7. Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.
    Bennardello F; Curciarello G
    Blood Transfus; 2013 Oct; 11(4):518-27. PubMed ID: 23867179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden.
    Filbey D; Hanson U; Wesström G
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):687-92. PubMed ID: 7572101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
    Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
    Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch].
    de Vrijer B; Harthoorn-Lasthuizen EJ; Oosterbaan HP
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2523-7. PubMed ID: 10627755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemolytic disease of newborn.
    Narang A; Jain N
    Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal suppression of Rh alloimmunization.
    Bowman JM
    Clin Obstet Gynecol; 1991 Jun; 34(2):296-303. PubMed ID: 1651184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
    Contreras M
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of anti-D prevention on the incidence of irregular erythrocyte antibodies in pregnant patients].
    Finger H; Drechsler HJ; Wirsing von König CH
    Immun Infekt; 1987 Nov; 15(6):208-15. PubMed ID: 3125103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of severe alloimmunization.
    Bennebroek Gravenhorst J
    Vox Sang; 1994; 67 Suppl 3():235-8. PubMed ID: 7975499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.